𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relative Hyperglucagonemia in L-Asparaginase-and Prednisone-induced Glucose Intolerance in Management of Acute Lymphocytic Leukemia

✍ Scribed by Turner, G. R.; Marks, J. F.; Buchanan, G. R.

Book ID
126928146
Publisher
SAGE Publications
Year
1983
Tongue
English
Weight
539 KB
Volume
22
Category
Article
ISSN
0009-9228

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vincristine and prednisone vs vincristin
Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children
✍ Herson, Jay ;Starling, Kenneth A. ;Dyment, Paul G. ;Humphrey, G. Bennett ;Pullen πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 332 KB

Second remission induction rates for vincristine and prednisone alone (VP) and vincristine, L-asparaginase, and prednisone (VLP) are compared for children with acute lymphocytic leukemia. No evidence of a significant difference between the second induction complete remission rate for VP (78.6%) and

Cyclophosphamide-asparaginase-vincristin
Cyclophosphamide-asparaginase-vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia
✍ Diane M. Komp; Stephen L. George; John Falletta; Vita J. Land; Kenneth A. Starli πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 2 views

A remission-induction regimen for childhood leukemia using cyclophosphamide, asparaginase, vincristine, and prednisone (CAVP) was compared to standard vincristine-prednisone (VP) induction. The more intensive regimen was associated with a lower complete remission rate (81% vs 93%) and a higher early

L-asparaginase used with cytosine arabin
L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone
✍ Smithson, William A. ;Gilchrist, Gerald S. ;Burgert, E. Omer πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 458 KB

## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with L‐asparaginase and cytosine arabinoside (1‐β‐D‐arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1

Optimal use of L-asparaginase (NSC-10922
Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia
✍ Jones, Barbara ;Holland, James F. ;Glidewell, Oliver ;Jacquillat, Claude ;Weil, πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 800 KB

## Abstract Between 1971 and 1974, 646 evaluable patients under 20 years of age with previously untreated acute lymphocytic leukemia were treated according to Cancer and Leukemia Group B (formerly Acute Leukemia Group B) Protocol 7111. On a random basis, they received a 10‐day course of 1,000 units